naltrexone hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
45 FDA-registered drug labelers
A-S Medication Solutions
Accord Healthcare, Inc.
ALMON HEALTHCARE PRIVATE LIMITED
American Health Packaging
Aphena Pharma Solutions - Tennessee, LLC
Aspen Oss B.V.
AvKARE
Bryant Ranch Prepack
Chartwell RX, LLC
DARMERICA, LLC
Elite Laboratories, Inc.
FRANCOPIA
Galenova Inc
Golden State Medical Supply, Inc.
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Kalchem International inc
LETCO MEDICAL, LLC
Major Pharmaceuticals
MEDISCA Inc.
Nalpropion Pharmaceuticals LLC
NCS HealthCare of KY, LLC dba Vangard Labs
Noramco, LLC
NuCare Pharmaceuticals Inc.
NURAY CHEMICALS PRIVATE LIMITED
Pharma Source Direct, Inc.
Precision Dose Inc.
Professional Compounding Centers of America
Professional Compounding Centers of America dba PCCA
Proficient Rx LP
REMEDYREPACK INC.
RUSAN PHARMA LTD
S.A.L.A.R.S. SOCIET AZIONARIA LABORATORI ALCALOIDI RIFORNIMENTI SANITARI S.P.A.
Saneca Pharmaceuticals a.s.
Sanofi Winthrop Industrie
Siegfried AG
Siegfried PharmaChemikalien Minden Gmbh
Siegfried USA, LLC
SpecGx LLC
STHREE CHEMICALS PRIVATE LIMITED
SUN PHARMACEUTICAL INDUSTRIES, INC.
TAGI Pharma Inc.
Wavelength Enterprises Ltd.
Willow Birch Pharma Inc.
Willow Birch Pharma, LLC
Xenex Laboratories Inc
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Naltrexone Hydrochloride
- •Contrave Extended-Release
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
resolved
Naltrexone Hydrochloride Tablet
02/29/2024Chemical Identity
CAS16676-29-2
PubChem CID5485201
DTXSIDDTXSID50937236
FormulaC20H24ClNO4
Mol. Weight377.9 g/mol
SMILESC1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl
Data Sources
54852012026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/naltrexone hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/naltrexone hydrochloride.json
CAS 16676-29-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 16676-29-22026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json